Suzanne Egyházi Brage

Melanoma-Educated CD14+ Cells Acquire a Myeloid-Derived Suppressor Cell Phenotype through COX-2–Dependent Mechanisms

Yumeng Mao, Isabel Poschke, Erik Wennerberg et al. · Cancer Research · 2013 · 186 citations

Life Sciences, Immunology, Oncology +17

Targeting CDK2 overcomes melanoma resistance against BRAF and Hsp90 inhibitors

Alireza Azimi, Stefano Caramuta, Brinton Seashore‐Ludlow et al. · Molecular Systems Biology · 2018 · 68 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

MGMT promoter methylation is associated with temozolomide response and prolonged progression‐free survival in disseminated cutaneous melanoma

Rainer Tuominen, Rosalyn Jewell, Joost J. van den Oord et al. · International Journal of Cancer · 2014 · 54 citations · Full text

Medicine, Oncology, Pharmacology +15

Silencing FLI or targeting CD13/ANPEP lead to dephosphorylation of EPHA2, a mediator of BRAF inhibitor resistance, and induce growth arrest or apoptosis in melanoma cells

Alireza Azimi, Rainer Tuominen, Fernanda Costa Svedman et al. · Cell Death and Disease · 2017 · 49 citations · Full text

Medicine, Molecular Biology, Oncology +17

Proteomics analysis of melanoma metastases: association between S100A13 expression and chemotherapy resistance

Alireza Azimi, Maria Pernemalm, Marianne Frostvik Stolt et al. · British Journal of Cancer · 2014 · 43 citations · Full text

Life Sciences, Biochemistry, Chemotherapy +16